RxDoctor Payments DataLook up a doctor →

Victor Lin, MD

Hematology & Oncology · Baton Rouge, LANPI 1568806818

Payments from drug & device makers

$2,303,682in general payments, 2019–2025

Across 467 payments — averaging $4932.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$957K
  • Eli Lilly$236K
  • Merck$235K
  • AstraZeneca$191K
  • AVEO Pharmaceuticals, Inc.$178K
  • Genentech, Inc.$136K
  • plus $370K from 54 others
$6,101in research payments, 2019–2025

Across 2 payments — averaging $3050.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$6K

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer44$956,696
Eli Lilly8$236,027
Merck23$235,303
AstraZeneca(2 entities)48$190,805
AVEO Pharmaceuticals, Inc.31$178,268
Genentech, Inc.16$136,376
Bristol Myers Squibb17$133,288
Regeneron16$61,774
GSK28$51,912
Beigene, Ltd.18$38,520
Janssen Research & Development, LLC3$27,291
Beigene USA, Inc.11$25,972
Novartis10$23,451
Boehringer Ingelheim Pharma GmbH & Co.kg1$1,242
Bayer4$955
Roche Molecular Systems, Inc.2$666
E.r. Squibb & Sons, L.L.C.8$414
Daiichi Sankyo Inc.16$385
Genentech USA, Inc.16$321
Johnson & Johnson17$315
Boehringer Ingelheim International GmbH1$278
AbbVie10$224
Takeda Pharmaceuticals U.S.A., Inc.6$210
Siemens Medical Solutions USA, Inc.1$197
Sanofi9$160
Pharmaessentia USA Corporation7$160
Medtronic1$150
Eagle Pharmaceuticals, Inc.1$149
ADC Therapeutics America, Inc.2$140
Adaptive Biotechnologies Corporation6$131
Incyte Corporation6$126
Lilly USA, LLC3$125
Regeneron Healthcare Solutions, Inc.6$120
Seagen Inc.2$115
Springworks Therapeutics, Inc.6$101
Sobi, Inc5$98
Array Biopharma Inc6$95
Caris MPI, Inc.2$95
Jazz Pharmaceuticals Inc.4$82
Sanofi-aventis U.S. LLC1$80
Gilead4$71
Beone Medicines USA, Inc.4$71
Exelixis Inc.3$66
Ipsen Biopharmaceuticals, Inc3$63
Amgen1$60
Cumberland Pharmaceuticals, Inc.3$51
Spectrum Pharmaceuticals Inc.3$51
Servier Pharmaceuticals LLC2$34
Deciphera Pharmaceuticals Inc.2$32
Karyopharm Therapeutics Inc.2$30
Astellas Pharma US Inc1$28
Geron Corporation1$26
Fennec Pharmaceuticals, Inc.1$25
Eisai Inc.1$23
Kyowa Kirin, Inc.1$20
Alnylam Pharmaceuticals Inc.1$19
Dendreon Pharmaceuticals LLC1$18
Tempus AI, Inc1$18
Syndax Pharmaceuticals, Inc.1$17
Pharmacosmos Therapeutics Inc.1$17

How this compares

$2,303,682 in reported general payments places this provider in the 95th percentile of 183 hematology & oncology providers in Louisiana.

See all hematology & oncology providers in Louisiana →

Medicare billing

Part B allowed, 2024
$55,042
Medicare patients
17
Services billed
2,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Baton Rouge

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →